Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Endonovo Therapeutics (ENDV) Short-Term Debt repayments (2016 - 2018)

Endonovo Therapeutics has reported Short-Term Debt repayments over the past 3 years, most recently at $71700.0 for Q4 2018.

  • Quarterly results put Short-Term Debt repayments at $71700.0 for Q4 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $87000.0 (changed N/A YoY), and the annual figure for FY2018 was $87000.0, up 656.52%.
  • Short-Term Debt repayments for Q4 2018 was $71700.0 at Endonovo Therapeutics, up from $5000.0 in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for ENDV hit a ceiling of $73000.0 in Q3 2015 and a floor of $5000.0 in Q2 2016.
  • Median Short-Term Debt repayments over the past 3 years was $15100.0 (2015), compared with a mean of $35020.0.